Australia · Health Care · AUD (Thousands) · Annual
Key financials
AUD|Thousands
ROE
-29.68%
2026 (actual)
ROA
-29.2%
2026 (actual)
Gross Margin
-
Net Margin
-
Total Assets
A$15,183.72K
2026 (actual)
Net Income
-A$4,693.16K
2026 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
AUD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+100.4 pt
Company
ROA
-20.9 pt
Company
Total Assets
-17.3%
Company
Sector average (own scale)
Net Income
-34%
Company
Sector average (own scale)
Detailed data
AUD|Thousands
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD? It covers the balance sheet, income statement, cash flow and Equlion model projections.